Tailored workouts may keep elderly cancer patients on their feet

NCT ID NCT01432067

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether giving older cancer patients (70+) personalized physical activity advice helps them maintain physical function and independence during curative cancer treatment. Over 300 participants were randomly assigned to either a standard exercise guide or a program tailored to their abilities. The main goal was to see if tailored advice could prevent a decline in mobility and daily living skills over one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized physical activity advice
What this could lead to
If successful, this could show that tailored exercise programs help older cancer patients stay independent and maintain quality of life during treatment.
What could go wrong
This is a completed study with results, but the intervention is behavioral and may not work for everyone. Benefits may depend on individual adherence and health status.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

302 people

The number who actually took part.

Started

Oct 2011

Finished

Jun 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 70 years old or older * Curative cares for cancer by chemotherapy and/ or surgery and/or hormonotherapy and/ or radiotherapy * Patient with histologically proven lymphoma or carcinoma : * Colon, rectum or anal canal Cancer * Breast Cancer * Esophageal cancer * Otolaryngology Cancer * Kidney cancer * hepatocellular carcinoma * Stomach Cancer * Pancreatic cancer * Bile duct cancer * Ovarian Cancer * All lymphoma diffuse large B-cell and all peripheral T-cells lymphomas * All low-grade lymphoma: lymphocytes, lymphocytes and plasma cells, follicular, mantle, marginal zone (MALT and others) * Prostate cancer * Bladder Cancer * Lung cancer * adenocarcinoma of unknown primary origin compatible with previous quoted origin * Performance status (ECOG) \<4 * Patient who had given oral consent to participate in the study Exclusion Criteria: * Palliative cares for cancer

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Motor Activity neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Mont de Marsan

    Mont-de-Marsan, France

  • CH de Dax

    Dax, France

  • CHRU Lille

    Lille, 59000, France

  • CHU Bordeaux - hôpital Xavier Arnozan

    Pessac, 33604, France

  • CHU Nancy hôpital adulte du brabois

    Vandœuvre-lès-Nancy, 54511, France

  • CHU de Bordeaux - Hôpital Saint André

    Bordeaux, 33000, France

  • CHU de Limoges, Hôpital Dupuytren

    Limoges, 87042, France

  • Centre Alexis Vautrin CLCC Nancy

    Vandœuvre-lès-Nancy, 54511, France

  • Centre Oscar Lambret, CLCC Lille

    Lille, 59020, France

  • Centre hospitalier de Senlis

    Senlis, 60309, France

  • Institut Bergonié

    Bordeaux, 33076, France

  • Institut jean Godinot, CLCC Reims

    Reims, 51056, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.